Truist Reaffirms Their Buy Rating for Lantheus and Keeps Price Target Unchanged at $96
Wednesday, 10 July 2024, 15:31
Truist Maintains Buy Rating for Lantheus
Truist has decided to keep their Buy rating for Lantheus unchanged, suggesting a positive stance on the company's prospects.
Price Target Stays Steady at $96
The price target of $96 remains the same, indicating Truist's belief in the current valuation and growth potential of Lantheus.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.